BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 29557233)

  • 1. Aetiology of recurrent miscarriage and the role of adjuvant treatment in its management: a retrospective cohort review.
    Dobson SJA; Jayaprakasan KM
    J Obstet Gynaecol; 2018 Oct; 38(7):967-974. PubMed ID: 29557233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time to conception and time to live birth in women with unexplained recurrent miscarriage.
    Kaandorp SP; van Mens TE; Middeldorp S; Hutten BA; Hof MH; van der Post JA; van der Veen F; Goddijn M
    Hum Reprod; 2014 Jun; 29(6):1146-52. PubMed ID: 24682612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-visualized pregnancy losses are prognostically important for unexplained recurrent miscarriage.
    Kolte AM; van Oppenraaij RH; Quenby S; Farquharson RG; Stephenson M; Goddijn M; Christiansen OB;
    Hum Reprod; 2014 May; 29(5):931-7. PubMed ID: 24603132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspirin or anticoagulants for treating recurrent miscarriage in women without antiphospholipid syndrome.
    Kaandorp S; Di Nisio M; Goddijn M; Middeldorp S
    Cochrane Database Syst Rev; 2009 Jan; (1):CD004734. PubMed ID: 19160241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prevalence and impact of fibroids and their treatment on the outcome of pregnancy in women with recurrent miscarriage.
    Saravelos SH; Yan J; Rehmani H; Li TC
    Hum Reprod; 2011 Dec; 26(12):3274-9. PubMed ID: 21954281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of recurrent miscarriage.
    Sugiura-Ogasawara M; Ozaki Y; Suzumori N
    J Obstet Gynaecol Res; 2014 May; 40(5):1174-9. PubMed ID: 24754846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyroid peroxidase antibody in women with unexplained recurrent miscarriage: prevalence, prognostic value, and response to empirical thyroxine therapy.
    Yan J; Sripada S; Saravelos SH; Chen ZJ; Egner W; Li TC
    Fertil Steril; 2012 Aug; 98(2):378-82. PubMed ID: 22624672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of prior birth and miscarriage frequency on the prevalence of acquired and congenital uterine anomalies in women with recurrent miscarriage: a cross-sectional study.
    Jaslow CR; Kutteh WH
    Fertil Steril; 2013 Jun; 99(7):1916-22.e1. PubMed ID: 23472945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrent miscarriage and birth sex ratio.
    Li J; Liu L; Liu B; Saravelos S; Li T
    Eur J Obstet Gynecol Reprod Biol; 2014 May; 176():55-9. PubMed ID: 24666800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Midluteal serum progesterone concentration does not predict the outcome of pregnancy in women with unexplained recurrent miscarriage.
    Yan J; Liu F; Yuan X; Saravelos SH; Cocksedge K; Li TC
    Reprod Biomed Online; 2013 Feb; 26(2):138-41. PubMed ID: 23273755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does surgery improve live birth rates in patients with recurrent miscarriage caused by uterine anomalies?
    Sugiura-Ogasawara M; Lin BL; Aoki K; Maruyama T; Nakatsuka M; Ozawa N; Sugi T; Takeshita T; Nishida M
    J Obstet Gynaecol; 2015 Feb; 35(2):155-8. PubMed ID: 25058627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unexplained recurrent miscarriage: how can we explain it?
    Saravelos SH; Li TC
    Hum Reprod; 2012 Jul; 27(7):1882-6. PubMed ID: 22552692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A feasibility trial of screening women with idiopathic recurrent miscarriage for high uterine natural killer cell density and randomizing to prednisolone or placebo when pregnant.
    Tang AW; Alfirevic Z; Turner MA; Drury JA; Small R; Quenby S
    Hum Reprod; 2013 Jul; 28(7):1743-52. PubMed ID: 23585559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrent miscarriage.
    Horne AW; Alexander CI
    J Fam Plann Reprod Health Care; 2005 Apr; 31(2):103-7. PubMed ID: 15921544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perinatal outcomes in a subsequent pregnancy among women who have experienced recurrent miscarriage: a retrospective cohort study.
    Field K; Murphy DJ
    Hum Reprod; 2015 May; 30(5):1239-45. PubMed ID: 25759495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The one-stop recurrent miscarriage clinic: an evaluation of its effectiveness and outcome.
    Habayeb OM; Konje JC
    Hum Reprod; 2004 Dec; 19(12):2952-8. PubMed ID: 15388685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognosis for live birth in women with recurrent miscarriage: what is the best measure of success?
    Lund M; Kamper-Jørgensen M; Nielsen HS; Lidegaard Ø; Andersen AM; Christiansen OB
    Obstet Gynecol; 2012 Jan; 119(1):37-43. PubMed ID: 22183209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Recurrent miscarriage--causes, diagnostics and treatment].
    Larsen EC; Christiansen OB
    Ugeskr Laeger; 2012 Oct; 174(41):2448-52. PubMed ID: 23050684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Higher levels of procoagulant microparticles in women with recurrent miscarriage are not associated with antiphospholipid antibodies.
    Martínez-Zamora MA; Tàssies D; Creus M; Reverter JC; Puerto B; Monteagudo J; Carmona F; Balasch J
    Hum Reprod; 2016 Jan; 31(1):46-52. PubMed ID: 26534898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Number and sequence of preceding miscarriages and maternal age for the prediction of antiphospholipid syndrome in women with recurrent miscarriage.
    van den Boogaard E; Cohn DM; Korevaar JC; Dawood F; Vissenberg R; Middeldorp S; Goddijn M; Farquharson RG
    Fertil Steril; 2013 Jan; 99(1):188-192. PubMed ID: 23043688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.